Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Trevena, Inc. (TRVN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1400-0.0200 (-1.72%)
At close: 4:00PM EDT
1.1500 +0.01 (+0.88%)
After hours: 07:46PM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Trevena Announces Two OLINVYK® Presentations at ANESTHESIOLOGY® 2021

    Posters highlight safety and tolerability data in two complex patient populations at higher risk for adverse eventsCHESTERBROOK, Pa., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced two presentations at ANESTHESIOLOGY® 2021, the national conference for the American Society of Anesthesiologists (ASA). Both posters

  • TipRanks

    Is Trevena Stock a Buy Right Now? This Is What You Need to Know

    On Thursday, tiny King of Prussia, Pennsylvania-based biotech Trevena (TRVN) released the data from an Imperial College London trial involving 30 patients enrolled in the proof-of-concept study of its TRV027 treatment for hospitalized COVID-19 patients. "The results showed that TRV027 was well-tolerated and provided initial evidence of its potential to improve biomarker and clinical endpoints associated with COVID-19 disease severity and progression," reported Trevena, and patients treated with

  • Benzinga

    Trevena Posts TRV027 Proof-of-Concept Study In Hospitalized COVID-19 Patients

    Trevena Inc (NASDAQ: TRVN) has announced data from 30 patients enrolled in the proof-of-concept study of TRV027 in hospitalized COVID-19 patients. The results showed that TRV027 was well-tolerated and provided initial evidence of its potential to improve biomarker and clinical endpoints associated with COVID-19. The study was led and funded by Imperial College London, with additional support through the British Heart Foundation Imperial Centre for Research Excellence Award. Related: Trevena's TR

Advertisement
Advertisement